Sabra Health Care REIT's SWOT analysis: stock poised for growth amid healthcare real estate boom

Sabra Health Care REIT (SBRA) is demonstrating resilience post-pandemic with a 10.76% revenue growth and strong EBITDARM coverage in its skilled nursing portfolio, reporting Core FFO of $0.35 per share for Q1 2025. Management projects full-year 2025 Core FFO between $1.43 and $1.46 per share, slightly below consensus, while same-store Net Operating Income (NOI) growth in the Senior Housing Operating Portfolio (SHOP) assets has increased 17% year-over-year. Despite a consistent dividend policy and active growth strategy focusing on SHOP acquisitions, potential challenges include rising interest rates impacting acquisitions and the need for suitable operating partners.

Analysis

Sabra Health Care REIT (SBRA) is demonstrating a resilient recovery in the post-pandemic healthcare real estate market, evidenced by a 10.76% year-over-year revenue growth and a significant 17% same-store Net Operating Income (NOI) increase in its Senior Housing Operating Portfolio (SHOP) assets. The company reported Core Funds From Operations (FFO) of $0.35 per share for Q1 2025 and projects full-year 2025 Core FFO between $1.43 and $1.46 per share, a midpoint slightly below consensus expectations, alongside a healthy gross profit margin of 67.73%. SBRA maintains a strong dividend yield of 6.59%, supported by a 15-year payment history and an anticipated 81% Normalized Funds Available for Distribution (FAD) payout ratio for FY2025. Management is actively pursuing growth through a $200 million pipeline of SHOP acquisitions, expected to close by end-Q2 2025, and has improved its balance sheet, reducing leverage to 5.19x net debt to adjusted EBITDA through strategic equity issuance. While the skilled nursing portfolio shows robust EBITDARM coverage above 2x, potential headwinds include rising interest rates impacting acquisition attractiveness and the critical need to secure competent operating partners for its expanding SHOP segment; however, the current shortfall in senior housing development presents a favorable market dynamic for SBRA.

Key Decisions for Investors

• Investors should evaluate SBRA for its attractive 6.59% dividend yield and potential for FFO accretion driven by the strategic expansion of its high-performing Senior Housing Operating Portfolio (SHOP) assets, which saw 17% YoY same-store NOI growth.
• It is prudent to closely monitor the execution of the $200 million SHOP acquisition pipeline, the company's management of leverage currently at 5.19x, and its ability to navigate risks such as rising interest rates and securing proficient operating partners.
• Consider SBRA's valuation, noted by InvestingPro as slightly below Fair Value, and the potential for multiple expansion as the SHOP portfolio grows, while also factoring in the FY2025 Core FFO guidance of $1.43-$1.46 per share, which is slightly below consensus estimates.